R&D News | pharmaphorum

News

Valneva gets $41m grant to roll out chikungunya vaccine

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life

News

Study finds wearables deliver key insights in heart disease

Off-the-shelf consumer wearables have shown a benefit when used to monitor the response to treatment in patients with atrial fibrillation (AF) and heart failure (HF).

News

Innovent throws its hat further into China's GLP-1 ring

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and E

News

Jonah Sacha, head of pathobiology at OHSU's National Primate Research Centre

Study points to route for 'one and done' flu vaccine

Scientists in the US have developed a new universal form of influenza vaccine that they say could protect against all strains of the virus – and do away with the annual scramble to match sh

News

CDER director Patrizia Cavazzoni and CBER director Peter Marks

FDA launches innovation hub to spur rare disease R&D

The FDA has said it will create a rare disease innovation hub to help speed the development of new treatments and build connections between developers and the rare disease community.

News

Cardurion heads crop of sizeable bio financings

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.

Valneva gets $41m grant to roll out chikungunya vaccine

Study finds wearables deliver key insights in heart disease

Innovent throws its hat further into China's GLP-1 ring

Study points to route for 'one and done' flu vaccine

FDA launches innovation hub to spur rare disease R&D

Cardurion heads crop of sizeable bio financings

UK's Claret Capital raises €575m for European biotechs

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks